Effects of racemic, S- and R-indobufen on cyclooxygenase and lipoxygenase activities in human whole Mood
- 1 November 1990
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 191 (1) , 83-88
- https://doi.org/10.1016/0014-2999(90)94098-i
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- L-663,536 (MK-886) (3-[1-(4-chlorobenzyl)-3-t-butyl-thio-5-isopropylindol-2-yl]-2,2-dimethylpropanoic acid), a novel, orally active leukotriene biosynthesis inhibitorCanadian Journal of Physiology and Pharmacology, 1989
- Effect of R and S Enantiomers of Naproxen on Aggregation and Thromboxane Production in Human PlateletsJournal of Pharmaceutical Sciences, 1989
- Indobufen is a potent inhibitor of whole blood aggregation in patients with a high atherosclerotic riskThrombosis Research, 1987
- Biosynthesis, characterization and inhibition of leukotriene B4 in human whole bloodProstaglandins, 1987
- Inhibition of platelet function with indobufen: Correlation with plasma drug levelThrombosis Research, 1985
- Determination of the enantiomers of indoprofen in blood plasma by high-performance liquid chromatography after rapid derivatization by means of ethyl chloroformateJournal of Chromatography B: Biomedical Sciences and Applications, 1984
- Selective Cumulative Inhibition of Platelet Thromboxane Production by Low-dose Aspirin in Healthy SubjectsJournal of Clinical Investigation, 1982
- Indobufen, a new inhibitor of platelet aggregation. Studies in guinea pigsPharmacological Research Communications, 1979
- Pharmacokinetic, bioavailability and pharmacodynamic study of indobufen (K 3920), an inhibitor of platelet aggregation, after a single dose in manEuropean Journal of Clinical Pharmacology, 1979
- Isomeric inversion of ibuprofen (r)‐enantiomer in humansJournal of Pharmaceutical Sciences, 1976